Author:
Zhang Jiaoyang,Zhou Lingli,Zhang Yu,He Haibing,Yin Tian,Gou Jingxin,Wang Yanjiao,Tang Xing
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference32 articles.
1. Kim W, Haws H, Mangelson R, Peterson P, Whatcott C, Siddiqui-Jain A, et al. Alvocidib synergizes with cytarabine and daunorubicin (7+3) in preclinical models of acute myeloid leukemia. Haematologica. 2017;102:370.
2. Trusova VM, Deligeorgiev T, Gorbenko G. Liposomal co-encapsulation of two novel europium complexes and doxorubicin: fluorescence study. J Fluoresc. 2017;27(4):1359–63. https://doi.org/10.1007/s10895-017-2070-x.
3. Lei J, Cong S, Song M, Zhang W, Peng G, Li X, et al. Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy. Drug Dev Ind Pharm. 2018;44(4):570–81. https://doi.org/10.1080/03639045.2017.1405432.
4. Maakaron JE, Mims AS. Daunorubicin-cytarabine liposome (CPX-351) in the management of newly diagnosed secondary AML: a new twist on an old cocktail. Best Pract Res Clin Haematol. 2019;32(2):127–33. https://doi.org/10.1016/j.beha.2019.05.005.
5. Tardi PG, Dos Santos N, Harasym TO, Johnstone SA, Zisman N, Tsang AW, et al. Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo. Mol Cancer Ther. 2009;8(8):2266–75. https://doi.org/10.1158/1535-7163.MCT-09-0243.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献